• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Role of AGE Receptors in Diabetic Complications

Research Project

Project/Area Number 11557081
Research Category

Grant-in-Aid for Scientific Research (B).

Allocation TypeSingle-year Grants
Section展開研究
Research Field Metabolomics
Research InstitutionKumamoto University

Principal Investigator

HORIUCHI Seikoh  Kumamoto University, Biochemistry, Professor, 医学部, 教授 (10117377)

Co-Investigator(Kenkyū-buntansha) KOIKE Hiroyuki  Sankyo Pharmaceutical Co. LTD, Chief director, 第一生物研究所, 所長
YAMADA Nobuhiro  Tsukuba University, Professor, 臨床医学系, 教授 (40200729)
Project Period (FY) 1999 – 2000
Project Status Completed (Fiscal Year 2000)
Budget Amount *help
¥13,500,000 (Direct Cost: ¥13,500,000)
Fiscal Year 2000: ¥5,200,000 (Direct Cost: ¥5,200,000)
Fiscal Year 1999: ¥8,300,000 (Direct Cost: ¥8,300,000)
KeywordsDiabetic Complications / Maillard Reaction endproduct / AGE / AGE Receptor / Scavenger Receptor / RAGE / Galectin-3 / Reverse Cholesterol Transport / ノックアウトマウス
Research Abstract

Long-term incubation of proteins with glucose leads, through the Schiff base and Amadori product, to the formation of advanced glycation end products (AGE). Recent studies of AGE-structures as well as the receptors for AGE (AGE-receptors) have emphasized the involvement of post-translational AGE-modification in aging and age-enhanced disease processes such as diabetic complications, atheroscleorosis and Alzheimer s disease. Three AGE receptors such as SR-A (scavenger receptor class A), galectin-3 and RAGE (receptor for AGE) have so far been identified. In the present study, we determined the significance of AGE receptors in the pathogenesis of diabetic complications. In vitro experiments using CHO cells overexpressed with human galectin-3 demonstrated endocytic uptake of ^<125>-AGE-BSA, acetylated-low density lipoprotein (LDL) and oxidized LDL, followed by lysosomal degradation, indicating that galectin-3 serves not only as an AGE-receptor but also as a receptor for modified LDL.Regard … More ing to the RAGE project, we successfully developed RAGE-transgenic mice, which highly expressed mouse RAGE in heart, kidney, liver, lung and macrophages. Their biochemical and morphological analyses are under way.
We previously discovered classA scavenger receptor (SR-A) serves as AGE-receptor in 1997. This notion was further extended in the present to class B scavenger receptor family such as CD-36 and SR-BI.CD-36-overexpressed CHO cells showed endocytic uptake and subsequent intracellular degradation of AGE-proteins, suggesting that AGE-protein generated in situ are recognized by CD36, which might contribute to the pathogenesis of diabetic macrovascular complications. By using SR-BI-overexpressed CHO cells (SR-BI-CHO), we clearly showed that SR-BI also serves as an AGE receptor. Furthermore, SR-BI-mediated selective uptake of cholesteryl esters of HDL as well as HDL-mediated cholesterol efflux from SR-BI-CHO cells were effectively competed for by AGE-ligands, indicating that AGE-ligands play a significant role in HDL-mediated reverse cholesterol transport in vivo. Less

Report

(3 results)
  • 2000 Annual Research Report   Final Research Report Summary
  • 1999 Annual Research Report
  • Research Products

    (98 results)

All Other

All Publications (98 results)

  • [Publications] Sakata,N. et al.: "Increased advanced glycation and products in atheroscleroric lesions of patient with end-stage renal disease"Atherosclerosis. 142. 67-77 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Abiko,T. et al.: "Relationship between autofluorescence and advanced glycation end products in diabetic lenses"Exp.Eye Res. 68. 361-366 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shibata N. et al.: "Advanced glycation endproducts are deposited in neuronal hyaline inclusions : a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation."Acta Neuropathol. 97. 240-246 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kato,S. et al.: "Astrocytic hyaline inclusions contain advanced glycation endproducts in familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation : imunohisto-chemical and immunoelectron microscopical analyses"Acta Neuropathol. 97. 260-266 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ando,K. et al.: "Membrane proteins of human erythrocytes are modified by advanced glycation end products (AGEs) during aging in the circulation."Biochem.Biophys.Res.Commun. 258. 123-127 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tajima,T. et al.: "Hereditary ceruloplasminemia deficiency increases advanced glycation end products in the brain (1999)"Neurology. 53. 619-622 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sugimoto,H. et al.: "Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy : aminoguanidine ameliorates the overexpression of tumor necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli"Diabetologia. 42. 878-886 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Honda,K. et al.: "Accumualtion of advaced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration."Nephrol.Dial.Transplant. 14. 1541-1549 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sasaki,T. et al.: "Induction of GM-CSF production of macrophages by advanced glycation end products of the Maillard reaction."Biosci.Biotechnol.Biochem. 63. 2011-2013 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shibayama,R. et al.: "Autoantibody Against N^ε-(carboxymehtyl) lysine : an advanced glycation end product of the Maillard reaction."Diabetes. 48. 1842-1849 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Iwashima,Y. et al.: "Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells."Biochem.Biophys Res.Commun. 264. 441-448 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sano,H. et al.: "Receptor for proteins modified by advanced glycation endproducts (AGE)-their functional role in atherosclerosis."Mech.Ageing Dev.. 107. 333-346 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shibata,N. et al.: "Morphological aspects of superoxide dismutase-1 mutation in amyotrophic lateral sclerosis and its transgenic mouse model"Acta.Histochem.Cytochem.. 32. 17-30 (1999)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kaji Y. at al.: "Advanced glycation end products in diabetic corneas."Invest.Ophthalmol.Vis.Sci.. 41. 362-368 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Uesugi,N. et al.: "Glycoxidative modification promotes renal AA amyloid Deposition."Nephrol.Dial.Transplant. 15. 355-365 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Imanaga,Y. et al.: "In vivo and in vitro evidence for glycoxidation of low density lipoprotein in human atherosclerotic plaques."Atherosclerosis. 150. 343-355 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shibata N. et al.: "Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation."Acta Neuropathol. 100. 275-284 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kato,S. et al.: "Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral Sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with G85R mutation."Acta Neuropathol.. 100. 490-505 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nyhlin,N. et al.: "Advanced glycation end product in familial amyloidotic polyneuropathy (FAP)"J.Intern.Med.. 247. 485-492 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Abiko,A. et al.: "Increased levels of advanced glycosylation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay."Metabolism. 49. 567-573 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nagai,N. et al.: "Glycolaldehyde, a reactive intermediate for advanced glycation endproducts, plays an important role in the generation of an active ligand for the macrophage scavenger receptor."Diabetes. 49. 1714-1723 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hamada,Y. et al.: "Epalrestat, an aldose reductase inhibitor, reduces the levels of Ne-(carboxymethy) lysine protein adducts and their precursors in erythrocytes from diabetic patients."Diabetes Care. 23. 1539-1544 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Matsumoto,K. et al.: "Endocytic uptake of advanced glycation endproducts by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor-A."Biochem.J.. 352. 233-240 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Iwashima,Y. et al.: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages"Biochem.Biophys.Res.Commun.. 277. 368-380 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Amano,S. et al.: "Advanced glycation end products in human optic nerve head"Br.J.Opthalmol. 85. 52-55 (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sakata,N. et al.: "Possible involvement of altered RGD sequence in reduced adhesive and spreading activities of advanced glycation end product-modified fibronectin to vascular smooth muscle cells"Connective Tissue Research. (In press). (2000)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohgami,N. et al.: "CD36, a member of class B scavenger receptor family, as a receptor for advanced glycation end products (AGE)."J.Biol.Chem. 276. 3195-3202 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Meng,J. et al.: "Tissue carboxymethyllysine in diabetic and non-diabetic patients with chronic renal failure : relevance to glycoxidation damage"Nephron. (In press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Zhu,W. et al.: "The Role of Galectin-3 in Endocytosis of Advanced Glycation End Products and Modified Low Density Lipoproteins."Biochem.Biophys.Res.Commun. 280. 1183-1188 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sakata,N. et al.: "Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis."Cardiovasc.Res.. 49. 466-475 (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohgami,N. et al.: "Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products."J.Biol.Chem.. (In press). (2001)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sakata, N., Imagana, Y., Meng, J., Tachikawa, Y., Takebayashi, S., Nagai, R., Horiuchi, S.: "Increased advanced glycation end products in atheroscleroric lesions of patients with end-stage renal disease."Atherosclerosis.. 142. 67-77 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Abiko, T., Abiko, A., Ishiko, S., Takeda, M., Horiuchi, S., and Yoshida, A.: "Relationship between autofluorescence and advanced glycation end products in diabetic lenses."Exp.Eye Res.. 68. 361-366 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shibata N., Hirano.A., Kato, S., Nagai, R., Horiuchi, S., Komori, T., Umahara, T., Asayama, K., Kobayashi, M.: "Advanced glycation endproducts are deposited in neuronal hyaline inclusions : a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation."Acta Neuropathol. 97. 240-246 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kato, S., Horiuchi, S., Nakashima, K., Hirano, A., Shibata, N., Nakano, I., Saito, M., Kato, M., Asayama, K., and Ohama, E.: "Astrocytic hyaline inclusions contain advanced glycation endproducts in familial amyotrophic lateral sclerosis with superoxide dismutase 1 gene mutation : imunohisto-chemical and immunoelectron microscopical analyses."Acta Neuropathol. 97. 260-266 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ando, K., Beppu, M., Kikugawa, K., Nagai, R., and Horiuchi, S.: "Membrane proteins of human erythrocytes are modified by advanced glycation end products (AGEs) during aging in the circulation."Biochem.Biophys.Res.Commun.. 258. 123-127 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Tajima, T., Kawanami, T., Nagai, R., Horiuchi, S., Kato, T.: "Hereditary ceruloplasminemia deficiency increases advanced glycation end products in the brain"Neurology. 53. 619-622 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sugimoto, H., Shikata, K., Wada, J., Horiuchi, S., Makino, H.: "Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy : aminoguanidine ameliorates the overexpression of tumor necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli."Diabetologia. 42. 878-886 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Honda, K., Nitta, K., Horita, S., Yumura, W., Nihei, H., Nagai, R., Ikeda, K., Horiuchi, S.: "Accumualtion of advaced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration."Nephrol.Dial.Transplant.. 14. 1541-1549 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sasaki, T., Horiuchi, S., Yamazaki, M., and Yui, S.: "Induction of GM-CSF production of macrophages by advanced glycation end products of the Maillard reaction"Biosci.Biotechnol.Biochem.. 63. 2011-2013 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shibayama, R., Araki, N., Nagai R., and Seikoh Horiuchi: "Autoantibody Against N^e-(carboxymehtyl)lysine : an advanced glycation end product of the Maillard reaction"Diabetes. 48. 1842-1849 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Iwashima, Y., Eto, M., Horiuchi, S., and Sane, H.: "Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells"Biochem.Biophys Res.Commun.. 264. 441-448 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sano, H., Nagai, R., Matsumoto, K., Horiuchi, S.: "Receptor for proteins modified by advanced glycation endproducts (AGE)-their functional role in atherosclerosis"Mech.Ageing Dev.. 107. 333-346 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shibata, N., Kobayashi, M., Hirano, A., Asayama, K., Horiuchi, S., Canto, M.C., Gurney, M.E.: "Morphological aspects of superoxide dismutase-1 mutation in amyotrophic lateral sclerosis and its transgenic mouse model."Acta.Histochem.Cytochem.. 32. 17-30 (1999)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kaji Y, Usui T, Oshika T, Matsubara M, Yamashita H, Araie M, Murata T, Ishibashi T, Nagai R, Horiuchi S, Amano S: "Advanced glycation end products in diabetic corneas."Invest.Ophthalmol.Vis.Sci.. 41. 362-368 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Uesugi, N.Sakata, N., Nagai, R., Johno, T., Horiuchi, S., Takebayashi, S.: "Glycoxidative modification promotes renal AA amyloid Deposition"Nephrol.Dial.Transplant.. 15. 355-365 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Imanaga, Y., Sakata, N., Takebayashia.S., Matsunaga, A., Sasaki, S., Arakawa, K., Nagai, R., Horiuchi, S., Itabe, H., and Takano, T.: "In vivo and in vitro evidence for glycoxidation of low density lipoprotein in human atherosclerotic plaques."Atherosclerosis.. 150. 343-355 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Shibata N, Nagai R, Miyata S, Jono T, Horiuchi S, Hirano A, Kato S, Sasaki S, Asayama K, Kobayashi M.: "Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation."Acta Neuropathol. 100. 275-284 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Kato, S., Horiuchi, S., Shibata, N., Cleveland, D.W., Nagashima, K., Nagai, R., Hirano, A., Takikawa, M., Kato, M., Nakano, I., and Ohama, E.: "Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral Sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with G85R mutation"Acta Neuropathol.. 100. 490-505 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nyhlin, N., Ando, Y, Nagai, R., Suhr, O., Sahly, M.EL, Terazaki, H., Yamashita, T., Ando, M., and Horiuchi, S.: "Advanced glycation end product in familial amyloidotic polyneuropathy (FAP)"J.Intern.Med.. 247. 485-492 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Abiko, A., Eto, M., Makino, I., Araki, N., and Horiuchi, S.: "Increased levels of advanced glycosylation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay"Metabolism.. 49. 567-573 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Nagai, N., Matsumoto, K., Sano, H., Suzuki, H., Araki, T., and Horiuchi, S.: "Glycolaldehyde, a reactive intermediate for advanced glycation endproducts, plays an imporant role in the generation of an active ligand for the macrophage scavenger receptor"Diabetes. 49. 1714-1723 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Hamada, Y., Nakamura, J., Naruse, K., Komori, T., Kato, K., Kasuya, Y., Nagai, R., Horiuchi, S., and Hotta, N.: "Epalrestat, an aldose reductase inhibitor, reduces the levels of Ne-(carboxymethy) lysine protein adducts and their precursors in erythrocytes from diabetic patients"Diabetes Care. 23. 1539-1544 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Matsumoto, K., Sano, H., Nagai, R., Suzuki, H., Kodama, T., Yoshida, M., Ueda, S., Smedsrod, B., and Horiuchi, S.: "Endocytic uptake of advanced glycation endproducts by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor-A."Biochem.J.. 352. 233-240 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Iwashima, Y., Eto, M., Hata, A., Kaku, K., Horiuchi, S., Ushikubi, F., and Sano, H.: "Advanced glycation end products-induced gene expression of scavenger receptors in cultured human monocyte-derived macrophages."Biochem.Biophys.Res.Commun.. 277. 368-380 (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Amano, S., Kaiji, Y., Oka, T., Machinami, R., Nagai, R., and Horiuchi, S.: "Advanced glycation end products in human optic nerve head"Br.J.Opthalmol.. 85. 52-55 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sakata, N., Sasamoto, Y, Meng, J., Ando, S., Uesugi, N., Takebayashi, S., Nagai, R., and Horiuchi, S.: "Possible involvement of altered RGD sequence in reduced adhesive and spreading activities of advanced glycation end product-modified fibronectin to vascular smooth muscle cells."Connective Tissue Research.. (in press). (2000)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohgami, N., Nagai, R., Ikemoto, M., Arai, H., Nakayama, H., and Horiuchi, S.: "CD36, a member of class B scavenger receptor family, as a receptor for advanced glycation end products (AGE)."J.Biol.Chem.. 276. 3195-3202 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Meng, J., Sakata, N., Imanaga, Y., Takebayashi, S., Nagai, R., and Horiuchi, S.: "Tissue carboxymethyllysine in diabetic and non-diabetic patients with chronic renal failure : relevance to glycoxidation damage."Nephron. (in press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Zhu, W., Sano, H., Nagai, R., Fukuhara, K., Miyazaki, A., Horiuchi, S.: "The Role of Galectin-3 in Endocytosis of Advanced Glycation End Products and Modified Low Density Lipoproteins"Biochem.Biophys.Res.Commun.. 280. 1183-1188 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Sakata, N., Uesugi, N., Takebayashi, S., Nagai, R., Jono, T., Horiuchi, S., Takeya, M., Itabe, H., Takano, T., Myint, T., Taniguchi, N.: "Glycoxidation and lipid peroxidation of low-density lipoprotein can synergistically enhance atherogenesis"Cardiovasc.Res.. 49. 466-475 (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohgami, N.Nagai, R., Miyazaki, A., Ikemoto, M., Arai, H., Horiuchi, S., Nakayama, H.: "Scavenger receptor class B type I-mediated reverse cholesterol transport is inhibited by advanced glycation end products."J.Biol.Chem.. (In press). (2001)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2000 Final Research Report Summary
  • [Publications] Ohgami N et al.,: "Scavenger receptor classB type I-mediated reverse cholesterol transport is inhibited by advanced glycation end product"J.Biol.Chem.. (In press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Meng J et al.,: "Tissue carboxymethyllysine in diabetic and non-diabetic patients with chronic renal failure : relevance to glycoxidation damage."Nephron.. (In press). (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Kyu-Kyu M et al.,: "Induction of acyl-coenzyme A : cholesterol acyltransferase-1 by 1,25-dihydroxyvitamin D3 or 9-cis-retinoic acid in undifferentiated THP-1 cells"J.Lipid Res.. (In press). (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ohgami N et al.,: "CD36, a member of class B scavenger receptor family, as a receptor for advanced glycation end products (AGE)."J.Biol.Chem.. 276. 3195-3202 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Sakata N et al.,: "Possible involvement of altered RGD sequence in reduced adhesive and spreading activities of advanced glycation end product-modified fibronectin to vascular smooth muscle cells."Connective Tissue Research. (In press). (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Amano S et al.,: "Advanced glycation end products in human optic nerve head"Br J.Ophthalmol.. 85. 52-55 (2001)

    • Related Report
      2000 Annual Research Report
  • [Publications] Iwashima Y et al.,: "Advanced glycation end products-induced gene expression of scaven receptors in cultured human monocyte-derived macrophages."Biochem.Biophys.Res.Commun.. 277. 368-380 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Matsumoto K et al.,: "Endocytic uptake of advanced glycation end products by mouse liver sinusoidal endothelial cells is mediated by a scavenger receptor distinct from the macrophage scavenger receptor-A (MSR-A)."Biochem.J.. 352. 233-240 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Hamada Y et al.,: "Epalrestat, an aldose reductase inhibitor, reduces the levels of Ne-(carboxymethy) lysine protein adducts and their precursors in erythrocytes from diabetic patients"Diabetes Care. 23. 1539-1544 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Ohgami N et al.,: "Glibenclamide acts as an inhibitor of acyl-CoA : cholesterol acyltransferase (ACAT) enzyme"Biochem.Biophys.Res.Commun.. 277. 417-422 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Nagai R et al.,: "Glycolaldehyde, a reactive intermediate for advanced glycation endproducts, plays an important role in the generation of an active ligand for the macrophage scavenger receptor."Diabetes. 49. 1714-1723 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Miyazaki A et al.,: "Granulocyte macrophage colony-stimulating factor plays a priming role in murine macroph growth induced by oxidized low density lipoprotein."Ann.N.Y.Acad.Sci.. 902. 342-342 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Abiko A et al.,: "Increased levels of advanced glycosylation end products in the kidney and liver from spontaneously diabetic Chinese hamsters determined by immunochemical assay."Metabolism.. 49. 567-573 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Nyhlin N et al.,: "Advanced glycation end product in familial amyloidotic polyneuropathy(FAP)."J.Int.Med.. 247. 485-492 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Kato S et al.,: "Advanced glycation endproduct-modified superoxide dismutase-1 (SOD1)-positive inclusions are common to familial amyotrophic lateral Sclerosis patients with SOD1 gene mutations and transgenic mice expressing human SOD1 with G85R mutation."Neuropathol. 100. 490-505 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Shibata N et al.,: "Nonoxidative protein glycation is implicated in familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation"Acta Neuropathol. 100. 275-284 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Imanaga Y et al.,: "In vivo and in vitro evidence for the glycoxidation of low density lipoprotein in human atherosclerotic plaques."Atherosclerosis . 150. 343-355 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Uesugi N et al.,: "Glycoxidative modification of AA amyloid deposits in renal tissue."Nephrol.Dial.Transplant.. 15. 355-365 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Biwa T et al.,: "Sites of action of protein kinase C and phosphatidylinositol 3-kinase are distinct from oxidized low density lipoprotein-induced macrophage proliferation."J.Biol.Chem.. 275. 5810-5816 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Sakashita N et al.,: "Localization of human acyl-Coenzyme A : cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues."Am.J.Pathol.. 156. 227-236 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Kaji Y et al.,: "Advanced glycation end products in diabetic corneas."Invest.Ophthalmol.Vis.Sci.. 41. 362-368 (2000)

    • Related Report
      2000 Annual Research Report
  • [Publications] Sakata N et al.: "Increased advanced glycation end products in atheroscleroric lesions of patients with endstage renal disease"Atherosclerosis. 142. 67-77 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Abiko,T et al.: "Relationship between autofluorescence and advanced glycation end products in diabetic lenses."Exp. Eye Res.. 68. 361-366 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Shibata N et al.: "Advanced glycation endproducts are deposited in neuronal hyaline inclusions: a study on familial amyotrophic lateral sclerosis with superoxide dismutase-1 mutation"Acta Neuropathol.. 97. 240-246 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kato S et al.: "Astrocytic hyaline inclusions contain advanced glycation endproducts in familial amyotrophiclateral sclerosis with superoxide dismutase 1 gene mutation: imunohisto-chemical and immunoelectron microscopical analyses."Acta Neuropathol.. 97. 260-266 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Ando K et al.: "Membrane proteins of human erythrocytes are modified by advanced glycation end products (AGEs) during aging in the circulation."Biochem. Biophys. Res. Commun.. 258. 123-127 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Uesugi N et al.: "Glycoxidative modification promotes renal AA amyloid"Deposition. Nephrol. Dial. Transplant.. 15. 355-365 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Tajima K et al.: "Hereditary ceruloplasminemia deficiency increases advanced glycation end products in the brain"Neurology. 53. 619-622 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Sugimoto H et al.: "Advanced glycation end products-cytokine-nitric oxide sequence pathway in the development of diabetic nephropathy: aminoguanidine ameliorates the overexpression of tumor necrosis factor-alpha and inducible nitric oxide synthase in diabetic rat glomeruli"Diabetologia. 42. 878-886 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Honda K et al.: "Accumualtion of advanced glycation end products in the peritoneal vasculature of continuous ambulatory peritoneal dialysis patients with low ultra-filtration"Nephrol. Dial. Transplant. 14. 1541-1549 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Sasaki T et al.: "The effect of interleukin (IL)-4 and IL-10 on macrophage growth-stimulating activities of oxidized low density lipoprotein (IDL), accetylated IDL and macrophage colony stimulating factor: the actrivity of oxidized IDL is refractory to the inhibitory cytokines"Pharm. Bull.. 22. 1002-1006 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Sasaki T et al.: "Induction of GM-CSF production of macrophages by advanced glycation end products of the Maillard reaction"Biosci. Biotechnol. Biochem.. 63. 2011-2013 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Shibayama R et al.: "Autoantibody Against Nε-(carboxymehtyl)lysine: an advanced glycation end product of the Maillard reaction"Diabetes. 48. 1842-1849 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Iwashima Y et al.: "Advanced glycation end product-induced peroxisome proliferator-activated receptor gamma gene expression in the cultured mesangial cells"Biochem. Biophys Res. Commun.. 264. 441-448 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Kaji Y et al.: "Advanced glycation en products in diabetic corneas"Invest. Ophthalmol. Vis. Sci.. 41. 362-368 (1999)

    • Related Report
      1999 Annual Research Report
  • [Publications] Imanaga Y et al.: "In vivo and in vitro evidences for glycoxidation of low density lipoprotein in human atherosclerotic plaques"Atherosclerosis. (in press).

    • Related Report
      1999 Annual Research Report

URL: 

Published: 1999-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi